Experimental studies onPNP suicide gene therapy of hepatoma

Abstract

To investigate the killing effect ofPNP/MeP-dR suicide gene system on hepatoma cells, pcDNA3. 0/PNP, an eukaryotic expression vector harboringE. coli PNP gene, was transfected into human hepatoma HepG2 cells by liposome-mediated method. A HepG2 cell line with stablePNP gene expression, HepG2/PNP, was established with presence of G418 selection. The cell growth curves were determined with trypan blue staining. The sensitivity of HepG2/PNP to MeP-dR and bystander effects were assayed by MTT and FCM methods. The enzymatic activity of the product ofPNP gene was determined by HPLC method. The cytotoxic effects of MeP-dR on HepG2/PNP cells were obvious (IC₅₀=4.5 μmol/L) and all HepG2/PNP cells were killed 4 days after the treatment with 100 μmol/L MeP-dR. In mixed cultures containing increasing percentages of HepG2/PNP cells, total population killing was demonstrated when HepG2/PNP cells accounted for as few as 5% of all HepG2 cells 8 days after the treatment with 100μmol MeP-dR. High-pressure liquid chromatography (HPLC) demonstrated that thePNP enzyme could convert MeP-dR into 6-MP.PNP/MeP-dR suicide gene system had an advantage over traditional suicide gene systems for hepatoma gene therapy. Our e results suggest that high-level bystander effects of this system result in significant anti-tumor responses to hepatoma gene therapy, especiallyin vivo.

Keywords

PNP/MeP-dR suicide gene system / hepatoma / gene therapy

References

[1] HughesB W, WellsA H, BebokZ, et al. . Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res, 1995, 55(15): 3339-3339

[2] GadiV K, AlexanderS D, KudlowJ E, et al. . In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells. Gene Ther, 2000, 7(20): 1738-1738

[3] CaiX K, LinJ S, LiuZ Z, et al. . The constructions of pcDNA3.0/PNP-CD and pcDNA3.0/PNP and the detection of their expressions. Chin J Cancer Prev Treat (Chinese), 2004, 11(11): 1125-1125

[4] Cai X K, Lin J S, Liu Z Zet al. Constructions of two vectors harboring PNP gene under the control of two different promoters and their expressions. World Chin J Digestol (Chinese), 12, (9):2036.

[5] SorscherE J, PengS, BebokZ, et al. . Tumor cell by-stander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Ther, 1994, 1(4): 233-233

[6] HughesB W, KingS A, AllanP W, et al. . Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase. J Biol Chem, 1998, 273(4): 2322-2322

[7] McCartJ A, WangZ H, XuH, et al. . Development of a melanoma-specific adenovirus. Mol Ther, 2002, 6(4): 471-471

[8] RubsamL Z, BoucherP D, MurphyP J, et al. . Cytotoxicity and accumulation of ganciclovir tri-phosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase- expressing human glioblastoma cells. Cancer Res, 1999, 59(3): 669-669

[9] LiZ, ShanmugamN, KatayoseD, et al. . Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase. Cancer Gene Ther, 1997, 4(2): 113-113

[10] GadiV K, AlexanderS D, WaudW R, et al. . A long-acting suicide gene toxin, 6-methylpurine, inhibits slow growing tumors after a single administration. J Pharmacol Exp Ther, 2003, 304(3): 1280-1280